113 related articles for article (PubMed ID: 6546171)
1. [Tissue polypeptide antigen (TPA) in non-neoplastic diseases].
Ruibal A; Durán Bellido P; Salgado A; García Bragado F; Monné J; Domenech-Torné FM; Salvador L
Rev Esp Oncol; 1984; 31(3):421-5. PubMed ID: 6546171
[TBL] [Abstract][Full Text] [Related]
2. [Importance of the tissue polypeptide antigen level in neoplastic patients. Its correlation with other tumor markers].
Ruibal A; Durán P; Lafuerza A; Bodi R; Solé LA; Rubio D; Ibarz L; De Torres JA; Domenech-Torné FM; Salvador L
Rev Esp Oncol; 1984; 31(3):409-14. PubMed ID: 6546169
[TBL] [Abstract][Full Text] [Related]
3. [Serum tissue polypeptide antigen (TPA) in patients with urogenital cancer].
Matsushima M; Kuwabara T; Miyamae K; Hachiya A; Kawahara M; Fukasawa K; Yagishita T; Tajima M; Sawamura Y; Shirai M
Hinyokika Kiyo; 1984 Jul; 30(7):869-75. PubMed ID: 6507205
[TBL] [Abstract][Full Text] [Related]
4. [Measurement of serum tissue polypeptide antigen (TPA) in patients with malignant tumor using prolifigen TPA-M "Daiichi" kit].
Sakahara H; Endo K; Torizuka K; Itoh K; Ohuchi N; Inaba N; Miyaji Y; Takayama M; Ishii K; Takagi H; Konishi J; Fukuoka M; Fukuchi M; Ohkawa J; Kagawa S; Kondo S; Shirouzu K; Iguchi H
Gan To Kagaku Ryoho; 1996 May; 23(6):733-43. PubMed ID: 8645025
[TBL] [Abstract][Full Text] [Related]
5. [Evaluation of serum tissue polypeptide antigen (TPA) in patients with urogenital cancer].
Tozuka K; Yonese Y; Nakagami Y; Minowa T; Hiraoka Y; Yamada N; Hikima N; Ishii Y; Tannowa K; Fujioka Y
Gan To Kagaku Ryoho; 1984 May; 11(5):1078-83. PubMed ID: 6721513
[TBL] [Abstract][Full Text] [Related]
6. [Serum tissue polypeptide antigen in the differential diagnosis of chronic pancreatitis and exocrine pancreatic tumors. Preliminary results].
Ruibal A; Encabo G
Rev Esp Oncol; 1983; 30(3):313-6. PubMed ID: 6571374
[TBL] [Abstract][Full Text] [Related]
7. Differential immunocytochemical localization of tissue polypeptide antigen (TPA) and carcinoembryonic antigen (CEA) in breast cancer.
Björklund V; Björklund B
Cancer Detect Prev; 1983; 6(1-2):193-8. PubMed ID: 6883380
[TBL] [Abstract][Full Text] [Related]
8. [Clinical significances of tissue polypeptide antigen in patients with gynecological malignancies].
Ueda M; Sudo N; Furuya M; Arakawa O; Ikarashi T
Nihon Sanka Fujinka Gakkai Zasshi; 1985 Nov; 37(11):2361-8. PubMed ID: 3001201
[TBL] [Abstract][Full Text] [Related]
9. [Serum and tissue quantification of tissue polypeptide antigen (TPA) in transitional cell carcinoma of the bladder].
Moreno Sierra J; Maestro de las Casas ML; Ortega Heredia MD; Blanco Jimenez E; Hermida Gutiérrez J; Resel Estévez L
Arch Esp Urol; 1994 Dec; 47(10):979-84. PubMed ID: 7864679
[TBL] [Abstract][Full Text] [Related]
10. Proliferation tissue polypeptide antigen distinguishes malignant mucinous cystadenocarcinomas from benign cystic tumors and pseudocysts.
Yang JM; Southern JF; Warshaw AL; Lewandrowski KB
Am J Surg; 1996 Jan; 171(1):126-9; discussion 129-30. PubMed ID: 8554126
[TBL] [Abstract][Full Text] [Related]
11. [Clinical evaluation of serum tissue polypeptide antigen (TPA) in patients with colo-rectal cancer].
Yukawa H; Kono N; Taniguchi K; Ieda K; Ono K; Yamamoto S; Koh K; Ohta M; Hayashido M; Yamaguchi K
Nihon Geka Hokan; 1984 Mar; 53(2):433-6. PubMed ID: 6508467
[No Abstract] [Full Text] [Related]
12. [Diagnostic value of tissue polypeptide antigen in pleural effusions with malignant pleural mesothelioma].
Tokuyama T; Yoneda T; Hamada K; Yoshikawa M; Fu A; Tomoda K; Nakaya M; Narita N; Tamura M; Kitamura K
Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Jan; 33(1):39-43. PubMed ID: 7699966
[TBL] [Abstract][Full Text] [Related]
13. [Tissue polypeptide antigen (TPA) in urological malignancies. I. S-TPA in bladder cancer patients].
Akiyama T; Tsujihashi H; Boku E; Nagai N; Matsuura T; Iguchi M; Yachiku S; Kurita T
Hinyokika Kiyo; 1983 Dec; 29(12):1635-40. PubMed ID: 6677110
[TBL] [Abstract][Full Text] [Related]
14. [Tissue polypeptide and carcinoembryonic antigens in patients with breast cancer].
Polevaia EB; Tkacheva GA; Ivanov VM; Koposova TL
Vopr Onkol; 1984; 30(3):9-13. PubMed ID: 6710954
[TBL] [Abstract][Full Text] [Related]
15. Preparation of tissue polypeptide antigen (TPA) from sera pools of cancer patients.
Romano TF; Evangelista M; Castelli M; Chersi A
Cancer Biochem Biophys; 1991 Nov; 12(3):205-9. PubMed ID: 1844912
[TBL] [Abstract][Full Text] [Related]
16. Clinical usefulness of serum TPA (tissue polypeptide antigen) in postsurgical diagnosis, prognosis and follow-up of lung cancer.
Volpino P; Cangemi V; Caputo V; Graziani EP; Mazzarino E; Gentili S; Borghese M
J Nucl Med Allied Sci; 1985; 29(3):241-4. PubMed ID: 4078636
[No Abstract] [Full Text] [Related]
17. [Experimental and clinical studies on a TPA kit, Prolifigen].
Ayabe Z; Ichiya Y; Yamaguchi I; Kuwabara Y; Wada M; Katsuragi M; Matsuura K
Radioisotopes; 1985 Apr; 34(4):230-3. PubMed ID: 4023281
[No Abstract] [Full Text] [Related]
18. Tissue polypeptide antigen (TPA) in comparison with mutations of tumour suppressor gene P53 (TP53) in patients with bladder cancer.
Ecke TH; Lenk SV; Schlechte HH; Loening SA
Anticancer Res; 2003; 23(2A):957-62. PubMed ID: 12820330
[TBL] [Abstract][Full Text] [Related]
19. Specificity and basis of the tissue polypeptide antigen.
Björklund B; Björklund V
Cancer Detect Prev; 1983; 6(1-2):41-50. PubMed ID: 6883392
[TBL] [Abstract][Full Text] [Related]
20. Tissue polypeptide antigen (TPA): usefulness in urological neoplasia.
Costello CB; Kumar S
Anticancer Res; 1986; 6(4):713-6. PubMed ID: 3752950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
